Related Experiment Videos
[Characterization of femA gene product by penicillin-binding protein assay]
Abstract:
To characterize the femA gene product by penicillin-binding protein (PBP) assay, cloned femA sequence was introduced into methicillin-sensitive femA mutant Staphylococcus aureus BB308 and into Escherichia coli JM109. Overproduced femA gene product was detected in the membrane fraction of the S. aureus and E. coli transformants by SDS-PAGE and Coomassie-blue staining, but no penicillin-binding activity was observed in the femA gene product. Both BB308 and its transformant produced PBP 2' and other PBPs, as much as clinically isolated methicillin-resistant S. aureus strains. The degree of restoration of methicillin resistance varied depending on the introduced femA sequences derived from six different S. aureus strains. A hypothetical mechanism of femA to affect beta-lactam resistance in S. aureus is discussed.
Insights
The femA gene product in Staphylococcus aureus does not directly bind penicillin but influences beta-lactam resistance. Its presence affects penicillin-binding protein levels and methicillin resistance restoration.
Area of Science:
- Microbiology
- Molecular Biology
- Genetics
Context:
- Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant public health threat.
- The femA gene is implicated in the mechanism of beta-lactam resistance in S. aureus.
- Understanding the function of femA is crucial for developing new therapeutic strategies.
Purpose:
- To characterize the function of the femA gene product.
- To investigate the role of femA in penicillin-binding protein (PBP) activity.
- To elucidate the mechanism by which femA contributes to beta-lactam resistance.
Summary:
- The femA gene sequence was introduced into Staphylococcus aureus and Escherichia coli to overproduce its product.
- The femA gene product was detected in cell membranes but showed no direct penicillin-binding activity.
- Both the femA mutant and its transformant produced PBP 2' and other PBPs, similar to MRSA strains.
Impact:
- This study reveals that femA does not directly bind penicillin but modulates beta-lactam resistance.
- The findings suggest a regulatory role for femA in the expression of essential PBPs.
- Understanding femA's mechanism can guide the development of novel anti-MRSA therapies.